DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant
DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

HENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) — DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational firm working companies inside 9 divisions and strategically buying and creating belongings to counterpoint the worth of its shareholders by way of calculated IPO spinoffs and a parametric share distribution technique, in the present day introduced Global BioLife, Inc. (“Global BioLife”), a division of the Company’s wholly owned subsidiary Impact BioMedical, was granted a patent (No. 2020119933780) from the China National Intellectual Property Administration (“CNIPA”) for 3F™, a Functional Fragrance Formulation (3F™) know-how that’s efficient as a mosquito repellant by way of a aromatic compound derived from botanical oils. This enhances the corresponding U.S. patent granted (U.S. 11,246,310) 3F™ is a particularly efficient mosquito repellant. The repellant is believed to incapacitate two of the three receptors that mosquitoes use to seek out sources of vitamin. “While current mosquito repellants goal solely the gustatory receptors in bugs, 3F™ makes use of a a number of receptor method by focusing on ionotropic, gustatory and olfactory receptors in bugs to supply a synergistic motion to repel bugs in addition to inhibit the flexibility of bugs to detect and search prey,” says Daryl Thompson, Director of Scientific Initiatives at Global BioLife and founding father of superior analysis firm GRDG Sciences, LLC (“GRDG”). While 3F™ has far-reaching purposes for on a regular basis life, crucial software may very well be saving lives. According to the National Institutes of Health, mosquitos are accountable for greater than one million deaths every year as a result of they’ll host quite a lot of illnesses together with malaria, dengue, West Nile yellow fever, Zika, chikungunya, and lymphatic filariasis. “3F™ is an revolutionary resolution for real-world issues that may be built-in into all kinds of on a regular basis merchandise by main manufacturers,” mentioned Frank Heuszel, President of Impact BioMedical. “The potential for this know-how within the huge market of China is immense, and we stay up for executing a licensing and commercialization technique round this product that drives sturdy worth for our shareholders whereas positively impacting customers of their on a regular basis lives.” The world mosquito repellant market was estimated at $6.9 billion in 2021 and anticipated to achieve $10.9 billion by the top of 2028, in keeping with knowledge from Zion Market Research. China is a number one market globally for the sale of insect repellant merchandise, with an rising demand for plant-based insect repellants being a key driver of market progress in recent times, in keeping with GMA, a Shanghai-based client advertising company. During the previous yr, Impact BioMedical has laid the groundwork for a future that’s centered on scientifically examined, high-impact options to world issues that people are going through from meals preservation to antibiotics to creating new methods to develop medicines. Impact Biomedical and GRDG introduced a U.S. patent (US 10,966,424) allowance for 3F™DB in June 2021. About Impact BioMedical, Inc.Impact BioMedical drives mission-oriented analysis, improvement, and commercialization of options for medical advances in human wellness and healthcare. By leveraging know-how and new science with strategic partnerships, Impact BioMedical offers advances in drug discovery for the prevention, inhibition, and therapy of neurological, oncology and immuno-related illnesses. Other thrilling applied sciences embrace a breakthrough different sugar aimed to fight diabetes and purposeful perfume formulations aimed on the industrial and medical business.   For extra info on Impact BioMedical go to http://impbio.com/. About DSS, Inc.DSS is a multinational firm working companies inside 9 divisions: Product Packaging, Biotechnology, Direct Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Digital Transformation, Secure Living, and Alternative Energy. DSS strategically acquires and develops belongings to counterpoint the worth of its shareholders by way of calculated IPO spinoffs and a parametric share distribution technique. Since 2019, below the steering of latest management, DSS has constructed the required basis for achievable progress by way of the formation of a diversified portfolio of corporations positioned to drive profitability in a number of excessive progress sectors. These corporations provide revolutionary, versatile, and real-world options that not solely present mutual advantages for companies and their clients, but additionally create sustainable worth and alternative for transformation. For extra info on DSS go to http://www.dssworld.com. Investor Contact:Dave Gentry, CEORedChip Companies [email protected] Safe Harbor DisclosureThis press launch incorporates forward-looking statements which are made pursuant to the protected harbor provisions throughout the which means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements embrace, however should not restricted to, statements associated to the Company’s supposed use of proceeds and different statements that aren’t historic details. Forward-looking statements are based mostly on administration’s present expectations and are topic to dangers and uncertainties which will trigger precise outcomes or occasions to vary materially from these projected. These dangers and uncertainties, lots of that are past our management, embrace: dangers referring to our progress technique; our potential to acquire, carry out below and keep financing and strategic agreements and relationships; dangers referring to the outcomes of improvement actions; our potential to draw, combine and retain key personnel; our want for substantial further funds; patent and mental property issues; competitors; in addition to different dangers described within the part entitled “Risk Factors” within the prospectus and in our different filings with the SEC, together with, with out limitation, our studies on Forms 8-Okay and 10-Q, all of which could be obtained on the SEC web site at www.sec.gov. Readers are cautioned to not place undue reliance on the forward-looking statements, which communicate solely as of the date on which they’re made and replicate administration’s present estimates, projections, expectations, and beliefs. We expressly disclaim any obligation or endeavor to launch publicly any updates or revisions to any forward-looking statements contained herein to replicate any change in our expectations or any modifications in occasions, circumstances, or circumstances on which any such assertion relies, besides as required by regulation.
Source: DSS, Inc.2022 GlobeNewswire, Inc., supply Press Releases

https://www.marketscreener.com/quote/inventory/DSS-INC-30897213/information/DSS-s-Impact-BioMedical-Receives-China-Patent-for-its-Functional-Fragrance-Formulation-Mosquito-Repe-40658616/

Recommended For You

About the Author: Jessica